Early Antiplatelet Therapy After Hemorrhagic Infarction in Acute Ischemic Stroke Treated With Intravenous Thrombolysis (HITs)

Clinical trial NCT04624295 · RECRUITING

Trial details

NCT number: NCT04624295
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Antiplatelet Therapy Hemorrhagic Infarction

Start date: 2021-01-01
Primary completion: 2025-12-31
Enrollment: 294

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.